PLERION 5 FLAVOURED CHEWABLE DOG
WORMER TABLETS
Contra-indications,
warnings, etc
Plerion vet chewable tablets for dogs from 5 kg
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active substances:
Each chewable tablet (Plerion 5) contains:
25 mg pyrantel (as embonate)
100 mg oxantel (as embonate)
25 mg praziquantel
CLINICAL PARTICULARS
Target species
Dogs
Indications for use, specifying the target
species
For the treatment of dogs harbouring mixed
parasitic infestations with the following adult stages of
nematode and cestode species:
Ascarids: Toxocara canis, Toxascaris leonina
Hookworms: Uncinaria stenocephala, Ancylostoma caninum
Whipworms: Trichuris vulpis
Tapeworms: Dipylidium caninum, Mesocestoides
spp., Taenia ovis, Taenia pisiformis, Taenia hydatigena,
Taenia multiceps, Echinococcus spp.
Contraindications
Do not use in dogs younger than 2 months of age.
Do not use in dogs weighing less than 2.5 kg.
Do not use in animals with known hypersensitivity to any of the
components of the product.
Use during pregnancy, lactation
The safety of the product has not been
established in bitches during pregnancy and lactation.
Laboratory studies in rats and rabbits have not
produced any evidence of teratogenic, foetotoxic or maternotoxic
effects. Use only according to the benefit/risk assessment by
the responsible veterinary surgeon.
Special warnings
Parasite resistance to any particular class of anthelmintic may
develop following frequent, repeated use of an anthelmintic of
that class.
When
D. caninum infection is present, concomitant
treatment against intermediate hosts, such as fleas and lice,
should be considered to prevent re-infection.
Dogs kept together or in kennels should be
treated at the same time.
Special precautions for use
Roundworm and Hookworm infections:
In some animals, Ancylostoma caninum and
Toxocara canis may not be totally eradicated by the
treatment, resulting in a continued risk of shedding of eggs
into the environment. Follow-up examinations of the faeces are
advisable and, based on the results of these examinations,
treatment with a nematodicidal product should be carried out, if
necessary.
In
debilitated or heavily infested animals, the product should be
used only according to a benefit/risk assessment by the
responsible veterinarian.
Special precautions to be taken by the person
administering the veterinary medicinal product to animals
Do not eat or drink while handling the product.
Wash your hands thoroughly with water and soap
immediately after use of the product.
This veterinary medicinal product may cause
irritation to eyes, any contact with the eyes should be avoided
while using the product. If accidental eye contact, flush eyes
immediately with plenty of water.
In case of accidental ingestion,
seek medical advice immediately and show the package leaflet
or the label to the physician.
Adverse reactions (frequency and seriousness)
In rare occasions vomiting and diarrhoea may be
observed following the treatment.
Although not observed in studies performed with this product,
anorexia may occur as it is a common adverse effect of products
containing praziquantel.
Interaction with other medicinal products and
other forms of interaction
Do not use
simultaneously with levamisole, piperazine or choline esterase
inhibitors.
The
chewable tablets contain a flavour and are taken voluntarily by
most dogs.
The tablets can be given directly to the dog or
with food.
To
ensure a correct dosage, body weight should be determined as
accurately as possible.
Echinococcosis represents a hazard for humans. As Echinococcosis
is a notifiable disease to the World Organisation for Animal
Health (OIE), specific guidelines on the treatment and
follow-up, and on the safeguard of persons, need to be obtained
from the relevant competent authority.
